Clinical Trial Update: Experimental Vaccine for Malaria [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 clinical trial evaluating an experimental malaria vaccine sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED